Journal article
Paclitaxel Versus Sirolimus Stents in Diabetic and Nondiabetic Patients
Abstract
BACKGROUND: Drug-eluting stents are more effective in reducing restenosis than bare-metal stents. Less certain is the relative performance of 2 widely used drug-eluting stents-sirolimus- and paclitaxel-eluting stents-in diabetic and nondiabetic patients undergoing percutaneous coronary intervention in routine clinical practice. We therefore studied the long-term effectiveness and safety of sirolimus versus paclitaxel stents overall and …
Authors
Chiu M; Ko DT; Austin PC; Cohen EA; Velianou JL; Goeree R; Blackhouse G; Tu JV
Journal
Circulation Cardiovascular Quality and Outcomes, Vol. 2, No. 2, pp. 96–107
Publisher
Wolters Kluwer
Publication Date
March 2009
DOI
10.1161/circoutcomes.108.826057
ISSN
1941-7713
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedAngioplasty, Balloon, CoronaryCohort StudiesCoronary Artery DiseaseDiabetic AngiopathiesDisease-Free SurvivalDrug-Eluting StentsFemaleHumansImmunosuppressive AgentsMaleMiddle AgedMultivariate AnalysisMyocardial InfarctionOntarioPaclitaxelProportional Hazards ModelsRegistriesSirolimusTubulin Modulators